Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Rise Therapeutics logo — Promoting human health and well-being.

Rise Therapeutics

Promoting human health and well-being.

Founded 2017 United States Rockville, United States 15 employees Grant Biotechnology, Health Care +2

General Information

Company Name Rise Therapeutics
Founded Year 2017
Location United States Rockville, United States
Employees 15
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Rise Therapeutics. To contact Rise Therapeutics, visit risetherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Rise Therapeutics

Rise Therapeutics is a US-based biotech startup focused on biotechnology, health care, health and wellness, and pharmaceutical industries. Established in 2017, the company is dedicated to promoting human health and well-being through the development of targeted immunological-based biologics. Their proprietary oral delivery platform sets them apart, enabling the creation of unique, first-in-class immune modulatory drugs for addressing conditions such as inflammation, autoimmunity, and cancer. As of now, there is no publicly available information about the last investment in Rise Therapeutics or the participating investors. However, the company's innovative approach to drug development and their focus on crucial areas of healthcare make them a potentially lucrative prospect for venture capitalists seeking opportunities in the biotech sector. With a strong emphasis on addressing unmet medical needs, Rise Therapeutics stands poised to make a significant impact in the field of immunological therapeutics.

No funding data available for Rise Therapeutics yet.

Rise Therapeutics Alternatives & Competitors

Rise Therapeutics vs
Synthekine
Synthekine United States

Synthekine a biotechnology company focused on discovery and developing best in class cytokine therap...

Series C
62 employees
Biotechnology, Health and Wellness
Rise Therapeutics vs
BioInvent International AB
BioInvent International AB Sweden

BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies.

IPO
139 employees
Biotechnology, Health Care
Rise Therapeutics vs
Allero Therapeutics BV
Allero Therapeutics BV The Netherlands

NEXT GENERATION IMMUNOTHERAPIES FOR IMMUNE DISORDERS

Grant
4 employees
Biotechnology, Pharmaceutical

FAQ About Rise Therapeutics

Promoting human health and well-being.
Rise Therapeutics was founded in 2017.
Rise Therapeutics is headquartered in Rockville, United States.
Rise Therapeutics operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical.
Rise Therapeutics has approximately 15 employees.
Top alternatives and competitors to Rise Therapeutics include Synthekine, BioInvent International AB, Allero Therapeutics BV, Biond Biologics Ltd, Attovia Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rise Therapeutics and Synthekine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rise Therapeutics, https://bouncewatch.com/company/rise-therapeutics, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes